SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001171843-18-006610
Filing Date
2018-09-18
Accepted
2018-09-18 16:00:57
Documents
4
Period of Report
2018-10-30

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT pre14a_091818.htm PRE 14A 713526
2 GRAPHIC logo.jpg GRAPHIC 3233
3 GRAPHIC proxycard_1.jpg GRAPHIC 77170
4 GRAPHIC proxycard_2.jpg GRAPHIC 50611
  Complete submission text file 0001171843-18-006610.txt   895437
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-23186 | Film No.: 181075680
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1